Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.36 billion in 2024, at a CAGR 11.48% to reach USD 6.46 billion by 2030. Global Translational Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Acute Ischemic Stroke Diagnosis Market by Diagnostics (Carotid Ultrasound, Cerebral Angiography, Computed Tomography), End-Use (Hospitals, Research & Diagnostic Centers) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 6.15% to reach USD 3.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Digital Biomarkers Market by Type (Hardware, Software), Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Musculoskeletal disorders, Neurological disorders), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.34 billion in 2024, at a CAGR 19.97% to reach USD 13.00 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomarkers ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Portable Ultrasound Devices Market by Device Type (Hand-Held, Mobile), Application (Cardiovascular, Gastric, Musculoskeletal), End User - Global Forecast 2024-2030
... to reach USD 4.29 billion in 2024, at a CAGR 8.26% to reach USD 6.92 billion by 2030. Global Portable Ultrasound Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Specialty PACS Market by Component (Hardware, Services, Software), Type (Cardiovascular PACS, Dermatology PACS, Oncology PACS), Deployment, End-User - Global Forecast 2024-2030
... expected to reach USD 4.88 billion in 2024, at a CAGR 8.23% to reach USD 7.89 billion by 2030. Global Specialty PACS Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
... 4.77 billion in 2023 and expected to reach USD 5.03 billion in 2024, at a CAGR 5.39% to reach USD 6.90 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
Cardiovascular Information System Market by Component (Hardware, Services, Software), System Types (CPACS, CVIS), Mode Of Operation, End-User - Global Forecast 2024-2030
... and expected to reach USD 74.76 million in 2024, at a CAGR 21.00% to reach USD 234.88 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cardiovascular Information System ... Read More
-
Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Global Forecast 2024-2030
... USD 6.67 billion in 2023 and expected to reach USD 7.53 billion in 2024, at a CAGR 13.36% to reach USD 16.05 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Global Forecast 2024-2030
... million in 2024, at a CAGR 17.53% to reach USD 1,887.63 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nutrigenomics Market. It offers a comprehensive assessment of vendors, ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Global Forecast 2024-2030
... estimated at USD 3.78 billion in 2023 and expected to reach USD 4.11 billion in 2024, at a CAGR 8.93% to reach USD 6.88 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Atherectomy Devices Market by Product (Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices), Application (Cardiovascular, Neurovascular, Peripheral Vascular), End User - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 1,039.43 million in 2024, at a CAGR 8.28% to reach USD 1,692.53 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Lymphedema Diagnostics Market by Technology (Bioimpedance Analysis, Computed Tomography, Lymphoscintigraphy), Disease (Cancer, Cardiovascular Disease, Inflammatory Diseases), End User - Global Forecast 2024-2030
... and expected to reach USD 35.46 million in 2024, at a CAGR 9.26% to reach USD 60.40 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lymphedema Diagnostics Market. ... Read More
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028
... management market is projected to reach USD 654 million by 2028 from USD 343 million in 2023, at a CAGR of 13.8% from 2023 to 2028. The growth of the market is driven by a ... Read More
-
Global Gene Therapy On Cardiovascular Disease Market Research Report 2024(Status and Outlook)
... doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential ... Read More
-
Cardiopulmonary Exercise Testing Market Research Report Forecast till 2030
... and aspiratory hypertension among others across the globe is driving the development of the cardiopulmonary exercise testing market. Cardiopulmonary exercise testing gives important symptomatic data and assists in deciding with practicing limit and utilitarian limits ... Read More
-
Stroke Post Processing Software Market Research Report Forecast till 2030
... ready for significant development driven by expanding stroke rates, high level imaging innovations, developing accentuation on convenient and precise analysis. As medical services suppliers focus on productive examination of clinical pictures for worked on quiet ... Read More
-
Percutaneous Coronary Intervention Market Research Report Forecast till 2032
... vigorous growth driven by mechanical progressions, expanding commonness of cardiovascular infections, and a rising maturing populace. With an emphasis on insignificantly obtrusive techniques and creative stent innovations, the market is ready to observe supported extension, ... Read More
-
Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032 Including: 1) By Offering: Software; Services 2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring 3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease 4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations Covering: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.
... Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research OrganizationsCovering: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc. Artificial Intelligence (AI) In Clinical Trials ... Read More
-
2024 Global Forecast for Cardiac Biomarkers (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global Anticoagulant Reversal Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
Research Assistance
